SPARC and cancer: The results of our DNA bisulfite sequencing of the SPARC promoter, spanning a region 1500 bp upstream and including exon1/intron1, allowed us to determine that the SPARC promoter hypermethylation could be identified in 80% of cases of human colorectal cancers (8 of 10 cancer).